Microsoft’s partnership with OpenAI is on the rocks
Microsoft’s joint venture with OpenAI, the developer of ChatGPT, appears to be in trouble. What now for the two groups?
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
For six years, the alliance between Microsoft and OpenAI, developer of ChatGPT, has been “one of the most successful partnerships in tech history”, says Berber Jin in The Wall Street Journal. Microsoft’s investment provided funding that fuelled OpenAI’s ascendancy in exchange for early access to OpenAI’s technology and nearly half of any profits. But now the relationship may be on the rocks. The two firms are at loggerheads over OpenAI’s $3 billion acquisition of the coding start-up Windsurf, which competes directly with Microsoft. And negotiations over OpenAI’s conversion into a for-profit company have stalled.
Even before this “behind-the-scenes dogfight”, the relationship between Microsoft and OpenAI was “already fraught”, say Bloomberg’s Brody Ford and Shirin Ghaffary. While it has put $14 billion into OpenAI, Microsoft has also backed rival AI start-ups and begun to construct its own AI models. OpenAI, meanwhile, has signed deals with “rival cloud-computing partners and spent much of the past two years building out a suite of paid subscription products for businesses, schools and individuals”.
Who has the advantage: Microsoft or OpenAI?
Experts believe that Microsoft has the upper hand, given how “crucial” converting to a for-profit entity is for the future of OpenAI, says the Financial Times. This is because most of the other investors who have put money into Sam Altman’s company only did so on the condition that they would be able to convert their equity investment into debt, or even ask for it back, if OpenAI failed to change its status. There are rumours that SoftBank, for instance, could cut its $30 billion investment by $10 billion if the conversion is not completed by the end of the year.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Still, OpenAI may have a few tricks of its own if Microsoft refuses its offer of a 33% stake in a restructured unit in exchange for foregoing rights to future profits, says Benj Edwads in Ars Technica. One of these is the “nuclear option” of seeking a federal regulatory review of the terms of its contract with Microsoft for potential antitrust law violations. In that case, OpenAI is likely to argue that “Microsoft is using its dominant position in cloud services and contractual leverage to suppress competition”.
OpenAI has several potential “sweeteners”, such as extending Microsoft’s exclusivity to OpenAI’s technology, or discounting access to new models, says Karen Kwok for Breakingviews. It could also give Microsoft a new class of shares that would give it outsized control, although this might be unpopular with other investors.
But if nothing else works, then OpenAI might be forced to scale back plans for developing new products, as it is currently “incinerating cash”. This would in turn “send ripples through the wider market, where investors have rushed into over $120 billion of generative AI start-up fundraising since 2023”. While this might not matter if AI becomes commoditised anyway, it would at least calm AI “mania”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
ISA fund and trust picks for every type of investor – which could work for you?Whether you’re an ISA investor seeking reliable returns, looking to add a bit more risk to your portfolio or are new to investing, MoneyWeek asked the experts for funds and investment trusts you could consider in 2026
-
The most popular fund sectors of 2025 as investor outflows continueIt was another difficult year for fund inflows but there are signs that investors are returning to the financial markets
-
Three companies with deep economic moats to buy nowOpinion An economic moat can underpin a company's future returns. Here, Imran Sattar, portfolio manager at Edinburgh Investment Trust, selects three stocks to buy now
-
Should you sell your Affirm stock?Affirm, a buy-now-pay-later lender, is vulnerable to a downturn. Investors are losing their enthusiasm, says Matthew Partridge
-
Beeks – building the infrastructure behind global marketsBeeks Financial Cloud has carved out a lucrative global niche in financial plumbing with smart strategies, says Jamie Ward
-
Investing in space – finding profits at the final frontierGetting into space has never been cheaper thanks to private firms and reusable technology. That has sparked something of a gold rush in related industries, says Matthew Partridge
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth